Date: 2025/05/20 - 19:31
A secondary heart attack could be prevented by replacing 30 minutes of sedentary behavior with light-intensity or moderate-to-vigorous-intensity physical activity, or even with sleep.
Date: 2025/05/19 - 22:32
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.
Date: 2025/05/17 - 01:32
“Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be much more common in women, men may be significantly more likely to die from it, according to new research.